Next Article in Journal / Special Issue
LncRNA Functional Screening in Organismal Development
Previous Article in Journal
A Review of IsomiRs in Colorectal Cancer
Previous Article in Special Issue
The Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) Is under Post-Transcriptional Control of microRNAs: Analysis of the Effects of agomiRNAs Mimicking miR-145-5p, miR-101-3p, and miR-335-5p
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Commentary

Small Nucleolar (Sno)RNA: Therapy Lays in Translation

Department of Genetics, The Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem 9190401, Israel
*
Author to whom correspondence should be addressed.
Non-Coding RNA 2023, 9(3), 35; https://doi.org/10.3390/ncrna9030035
Submission received: 5 May 2023 / Revised: 5 June 2023 / Accepted: 6 June 2023 / Published: 8 June 2023
(This article belongs to the Special Issue Recent Advances in Chemical Biology to Study and Target ncRNAs)

Abstract

The ribosome is one of the largest complexes in the cell. Adding to its complexity are more than 200 RNA modification sites present on ribosomal RNAs (rRNAs) in a single human ribosome. These modifications occur in functionally important regions of the rRNA molecule, and they are vital for ribosome function and proper gene expression. Until recent technological advancements, the study of rRNA modifications and their profiles has been extremely laborious, leaving many questions unanswered. Small nucleolar RNAs (snoRNAs) are non-coding RNAs that facilitate and dictate the specificity of rRNA modification deposition, making them an attractive target for ribosome modulation. Here, we propose that through the mapping of rRNA modification profiles, we can identify cell-specific modifications with high therapeutic potential. We also describe the challenges of achieving the targeting specificity needed to implement snoRNAs as therapeutic targets in cancers.
Keywords: snoRNAs; 2′-O-methylation; ribosome; therapy snoRNAs; 2′-O-methylation; ribosome; therapy

Share and Cite

MDPI and ACS Style

Rabany, O.; Nachmani, D. Small Nucleolar (Sno)RNA: Therapy Lays in Translation. Non-Coding RNA 2023, 9, 35. https://doi.org/10.3390/ncrna9030035

AMA Style

Rabany O, Nachmani D. Small Nucleolar (Sno)RNA: Therapy Lays in Translation. Non-Coding RNA. 2023; 9(3):35. https://doi.org/10.3390/ncrna9030035

Chicago/Turabian Style

Rabany, Ofri, and Daphna Nachmani. 2023. "Small Nucleolar (Sno)RNA: Therapy Lays in Translation" Non-Coding RNA 9, no. 3: 35. https://doi.org/10.3390/ncrna9030035

APA Style

Rabany, O., & Nachmani, D. (2023). Small Nucleolar (Sno)RNA: Therapy Lays in Translation. Non-Coding RNA, 9(3), 35. https://doi.org/10.3390/ncrna9030035

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop